Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2021-004057-23Phase 4Completed
Phase 4, open-label, single-arm trial of ethanol in hypersalivation, sponsored by Radboudumc. Primary endpoint: Adverse events. Started Jul 2021; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2021-004057-23.